To determine whether SARS-CoV-2–associated TCRs used in our analyses are associated with functional CD4+ T cell responses, we enriched CD4+ T cells from PBMCs collected from 3 people in our convalescent cohort who were hospitalized and admitted to intensive care for treatment of COVID-19. This evidence concerns the gene CD4 and COVID-19.